Breathe Well Live Well
Conditions: Bacterial Pneumonia; Viral Pneumonia; Acute Asthma
Intervention: Drug: Inhaled corticosteroid
Sponsors: Makerere University; Makerere University; University of Copenhagen
Recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial
Seeking Alpha Results announced this week of a clinical trial testing the drug dupilumab, made by the biotechnology company Regeneron Pharmaceuticals (REGN) and global pharmaceutical company Sanofi (SNY) gave hope to asthma sufferers and got the attention of … |
View full post on asthma – Google News
|
Monoclonal Antibody Dupilumab Safe And Effective In Asthma Phase IIa Trial
Science 2.0 A novel approach to obstructing the runaway inflammatory response implicated in some types of asthma has shown promise in a Phase IIa clinical trial, according to researchers. The randomized, double-blind, placebo-controlled trial tested the efficacy … |
View full post on asthma – Google News
|
Trial asthma drug targets lung inflammation – Medical Xpress
Medical Xpress Speaking in the lead up to World Asthma Day (7 May), respiratory health expert Associate Professor Sandra Hodge (University of Adelaide School of Medicine and Royal Adelaide Hospital) says the trial treatment is aimed at helping asthma sufferers who … |
View full post on asthma – Google News
|
Trial asthma drug targets lung inflammation
HealthCanal.com University of Adelaide researchers at the Royal Adelaide Hospital are involved in the world's biggest study of its kind investigating a possible new treatment for asthma. Clinical trials are underway looking at an antibiotic treatment which is hoped to … |
View full post on asthma – Google News
|
Cytos Rises After Asthma Drug Succeeds in Trial: Zurich Mover
Bloomberg In a trial among 63 patients in Germany, those treated with the drug, CYT003, had improved control of their asthma after treatment with inhaled corticosteroids stopped, while those who received a placebo saw their disease worsen, Cytos said in a … The Journal of Allergy and Clinical Immunology Publishes Phase 2a Study … |
View full post on asthma – Google News
 MENAFN.COM |
Invion starts second phase trial for asthma treatment
MENAFN.COM (MENAFN – ProactiveInvestors – Australia) Invion (ASX: IVX) has initiated the phase II "NIMA" clinical trial to investigate the use of INV102 in patients with mild asthma. The trail, which is funded by the U.S. National Institute of Allergy and … |
View full post on asthma – Google News
 Proactive Investors Australia |
Invion starts second phase trial for asthma treatment
Proactive Investors Australia Invion (ASX: IVX) has initiated the phase II “NIMA” clinical trial to investigate the use of INV102 in patients with mild asthma. The trail, which is funded by the U.S. National Institute of Allergy and Infectious Diseases through a cooperative … |
View full post on asthma – Google News
 Yahoo!7 News |
World-First Trial of Pregnancy Asthma Service
Newswise (press release) Newswise — Researchers in Australia will establish the world's first dedicated asthma service for pregnant women in a trial of what they hope will reduce the adverse effects of asthma on the growth and survival of babies. Associate Professor Vicki … Asthma support trial for pregnant women |
View full post on asthma – Google News
|
First Australian trial of pregnancy asthma service
HealthCanal.com Font size: Decrease font Enlarge font. University of Adelaide researchers will establish Australia's first dedicated asthma service for pregnant women in a trial of what they hope will reduce the adverse effects of asthma on the growth and survival of … Asthma support trial for pregnant women |
View full post on asthma – Google News